Tuffclassified

Canmab 150mg Injection contains the active ingredient trastuzumab, a monoclonal antibody used in the treatment of certain types of breast and stomach cancers. It works by targeting the HER2 protein, which promotes the growth of cancer cells, thereby inhibiting their proliferation. PRACTO.COM Uses: Breast Cancer: Canmab is indicated for HER2-positive breast cancer, both in early and advanced stages. Stomach Cancer: It is also used for HER2-positive metastatic gastric cancer. Administration: This medication is administered intravenously by a qualified healthcare professional in a clinical setting. The dosage and frequency depend on individual patient factors and the specific cancer being treated. PRACTO.COM Common Side Effects: Fever Headache Nausea and vomiting Diarrhea Weakness Shortness of breath Rash Back and muscle pain Patients should inform their doctor if these side effects persist or worsen. PRACTO.COM Precautions: Allergies: Avoid use if allergic to trastuzumab or any component of the injection. Heart Conditions: Inform your doctor of any pre-existing heart diseases, as Canmab can affect heart function. Pregnancy and Breastfeeding: Not recommended during pregnancy due to potential harm to the fetus. Women of childbearing potential should use effective contraception during treatment and for seven months after the last dose. Breastfeeding is not advised during treatment and for seven months post-treatment.